Literature DB >> 21371426

Fyn mediates transforming growth factor-beta1-induced down-regulation of E-cadherin in human A549 lung cancer cells.

An Na Kim1, Woo-Kwang Jeon, Kyu-Hyoung Lim, Hui-Young Lee, Woo Jin Kim, Byung-Chul Kim.   

Abstract

Transforming growth factor-beta (TGF-β) signaling positively contributes to the regulation of tumor metastasis. However, the underlying molecular mechanisms are less well defined. We here show that Fyn, a member of Src family tyrosine kinases, plays a critical role in mediating TGF-β1-induced down-regulation of E-cadherin in human A549 lung cancer cells. Blockade of Fyn with siRNA knockdown or ligand-binding defective mutant significantly lowered the ability of TGF-β1 to repress E-cadherin expression. Furthermore, our results demonstrated that Fyn facilitates TGF-β1-mediated suppression of E-cadherin through p38 kinase-dependent induction of Snail. Collectively, our findings identify a Fyn-p38-Snail cascade as a new signaling pathway mediating oncogenic TGF-β function.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371426     DOI: 10.1016/j.bbrc.2011.02.134

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Functional MUC4 suppress epithelial-mesenchymal transition in lung adenocarcinoma metastasis.

Authors:  Liuwei Gao; Jun Liu; Bin Zhang; Hua Zhang; Daowei Wang; Tiemei Zhang; Yang Liu; Changli Wang
Journal:  Tumour Biol       Date:  2013-09-15

2.  Reduced surface expression of epithelial E-cadherin evoked by interferon-gamma is Fyn kinase-dependent.

Authors:  David Smyth; Gabriella Leung; Maria Fernando; Derek M McKay
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

3.  Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.

Authors:  Eunji Jo; Seong Ji Park; Yu Sun Choi; Woo-Kwang Jeon; Byung-Chul Kim
Journal:  Neoplasia       Date:  2015-07       Impact factor: 5.715

Review 4.  Overcoming barriers and thresholds - signaling of oligomeric Aβ through the prion protein to Fyn.

Authors:  Hansen Wang; Carl He Ren; C Geeth Gunawardana; Gerold Schmitt-Ulms
Journal:  Mol Neurodegener       Date:  2013-07-16       Impact factor: 14.195

Review 5.  Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology.

Authors:  Dawn Mikelonis; Cheryl L Jorcyk; Ken Tawara; Julia Thom Oxford
Journal:  Orphanet J Rare Dis       Date:  2014-03-12       Impact factor: 4.123

6.  TGF-β mediated DNA methylation in prostate cancer.

Authors:  Chung Lee; Qiang Zhang; Xaolin Zi; Atreya Dash; Marcelo B Soares; Farahnaz Rahmatpanah; Zhenyu Jia; Michael McClelland; Dan Mercola
Journal:  Transl Androl Urol       Date:  2012-06

7.  Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.

Authors:  Pavlos Lampropoulos; Adamantia Zizi-Sermpetzoglou; Spyros Rizos; Alkiviadis Kostakis; Nikolaos Nikiteas; Athanasios G Papavassiliou
Journal:  Tumour Biol       Date:  2012-01-26

8.  The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasis.

Authors:  Changli Wang; Yanjun Su; Lianmin Zhang; Meng Wang; Jian You; Xiaoliang Zhao; Zhenfa Zhang; Jun Liu; Xishan Hao
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

9.  Expression analysis of genes and pathways associated with liver metastases of the uveal melanoma.

Authors:  Yuanyuan Zhang; Yong Yang; Lei Chen; Jianhong Zhang
Journal:  BMC Med Genet       Date:  2014-03-05       Impact factor: 2.103

10.  The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.

Authors:  Woo-Kwang Jeon; Jiyeon Choi; Seong Ji Park; Eun Ji Jo; Young K Lee; Seunghwan Lim; Jae-Hong Kim; John J Letterio; Fang Liu; Seong-Jin Kim; Byung-Chul Kim
Journal:  Oncotarget       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.